Cardiac Toxicity of Mediastinal Radiotherapy: Which Are the Critical Structures?
Authors:
- 20 May 2005
- journal article
- other
- Published by American Society of Clinical Oncology (ASCO) in Journal of Clinical Oncology
- Vol. 23 (15) , 3634-3636
Abstract
No abstract availableThis publication has 11 references indexed in Scilit:
- Role of MRI in clinical cardiologyThe Lancet, 2004
- Effects of geometric distortion in 0.2T MRI on radiotherapy treatment planning of prostate cancerRadiotherapy and Oncology, 2004
- Involved-Field Radiotherapy Is Equally Effective and Less Toxic Compared With Extended-Field Radiotherapy After Four Cycles of Chemotherapy in Patients With Early-Stage Unfavorable Hodgkin’s Lymphoma: Results of the HD8 Trial of the German Hodgkin’s Lymphoma Study GroupJournal of Clinical Oncology, 2003
- Radiation-associated cardiovascular diseaseCritical Reviews in Oncology/Hematology, 2003
- Late Medical Complications and Fatigue in Hodgkin’s Disease SurvivorsJournal of Clinical Oncology, 2001
- Active breathing control (ABC) for Hodgkin’s disease: reduction in normal tissue irradiation with deep inspiration and implications for treatmentInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2000
- Cardiac risk after mediastinal irradiation for Hodgkin's diseaseRadiotherapy and Oncology, 1998
- Cardiac lesions after mediastinal irradiation for Hodgkin's diseaseRadiotherapy and Oncology, 1994
- Cardiovascular mortality in a randomized trial of adjuvant radiation therapy versus surgery alone in primary breast cancerInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1992
- SEVERE CONSTRICTIVE PERICARDITIS AFTER SINGLE 16 MeV ANTERIOR MANTLE IRRADIATION FOR HODGKIN'S DISEASEThe Lancet, 1985